Clinical Trial Update: Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1 [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 1/2 study evaluating the safety and efficacy of EXG001-307 in patients with spinal muscular atrophy, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• EXG001-307

Snippet

Sponsor: Guangzhou Jiayin Biotech Ltd | Conditions: Spinal Muscular Atrophy Type I | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION